Review paper
Prescription Psychedelics: The Road from FDA Approval to Clinical Practice
Abstract
After languishing for decades from legal restrictions and stigma, research into psychedelic drugs is exploding, with the encouragement of the US Food and Drug Administration (FDA). Recent clinical trial successes suggest some long-banned drugs could soon be authorized as treatments for debilitating illnesses. Yet because of these drugs’ history, FDA approval would be just 1 important step in a complex process to transform these compounds into...
Paper Details
Title
Prescription Psychedelics: The Road from FDA Approval to Clinical Practice
Published Date
Jan 1, 2022
Volume
135
Issue
1
Pages
15 - 16
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History